Differential Immunohistochemical Expression of Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinase-2 in Cow Uteri with Adenomyosis During Follicular Phase

Overview

Journal Vet Res Commun

Publisher Springer

Specialty Veterinary Medicine

Date 2011 Jun 1

PMID 21626345

Citations 6

Authors

Lio Moreira

Eulogio Carlos Queiroz de Carvalho

Maria Clara Caldas-Bussiere

Affiliations

Soon will be listed here.

Abstract

The present investigation was intended to show a different immunohistochemical profile of matrix metalloproteinase-2 and Tissue inhibitor metalloproteinase-2 in bovine uteri with adenomyosis during follicular phase. Uterine samples of 32 cows in reproductive age were taken from the medial third of one of the uterine horns and grouped according to the adenomyosis degree (superficial and deep). Tissue sections (4 μm) were incubated overnight at 4°C with monoclonal antibody for matrix metalloproteinase-2 and Tissue inhibitor metalloproteinase-2. Staining intensities were evaluated in the luminal epithelium, ectopic and dystopic endometrial tissue (stroma, capillaries and glands), endometrial-myometrial border, myometrium, myometrial vessels (middle tunic and endothelium). The matrix metalloproteinase-2 expression was higher for deep adenomyosis samples, showing a differential mean reactivity in superficial endometrium, myometrial vessels, myometrium adjacent to adenomyotic focus and endometrial-myometrial border (P < 0.05). Moreover, matrix metalloproteinase-2 expression was higher in deep adenomyosis samples than that of Tissue inhibitor metalloproteinase-2 in almost all uterine structures analyzed (except for the endometrial and myometrial vessels and endometrial-myometrial border). The opposite was observed in the follicular phase, for both normal specimens and with superficial adenomyosis, where Tissue inhibitor metalloproteinase-2 expression was higher than that of matrix metalloproteinase-2. In conclusion, a differential pattern of matrix metalloproteinase-2 and Tissue inhibitor metalloproteinase-2 was observed in cow uteri with adenomyosis.

Citing Articles

The effectiveness of L. extracts on endometriotic implant regression in rat endometriosis model.

Ozel S, Suntar I, Ercan Gokay N, Turkmenoglu T, Demirel M Vet Res Forum. 2021; 11(4):305-309.

PMID: 33643581 PMC: 7904131. DOI: 10.30466/vrf.2019.105229.2500.

Effect of ovarian steroids on vascular endothelial growth factor a expression in bovine uterine endothelial cells during adenomyosis.

Lupicka M, Zadroga A, Szczepanska A, Korzekwa A BMC Vet Res. 2020; 15(1):473.

PMID: 31888628 PMC: 6937854. DOI: 10.1186/s12917-019-2222-0.

Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia.

Chen J, Khalil R Prog Mol Biol Transl Sci. 2017; 148():87-165.

PMID: 28662830 PMC: 5548443. DOI: 10.1016/bs.pmbts.2017.04.001.

Expression of pluripotency markers in the bovine uterus with adenomyosis.

Lupicka M, Socha B, Szczepanska A, Korzekwa A Reprod Biol Endocrinol. 2015; 13:110.

PMID: 26416515 PMC: 4587725. DOI: 10.1186/s12958-015-0106-0.

Altered matrix metalloproteinase-2 and -9 expression/activity links placental ischemia and anti-angiogenic sFlt-1 to uteroplacental and vascular remodeling and collagen deposition in hypertensive pregnancy.

Li W, Mata K, Mazzuca M, Khalil R Biochem Pharmacol. 2014; 89(3):370-85.

PMID: 24704473 PMC: 4034157. DOI: 10.1016/j.bcp.2014.03.017.

References

Yamada O, Takahashi T, Hashizume K . The dynamic expression of extracellular matrix in the bovine endometrium at implantation. J Vet Med Sci. 2002; 64(3):207-14. DOI: 10.1292/jvms.64.207. View

Hirata M, Sato T, Tsumagari M, Hashizume K, Ito A . Discoordinate regulation of expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases-3 in bovine endometrial stromal cells on type-I collagen gel. Biol Pharm Bull. 2003; 26(7):1013-7. DOI: 10.1248/bpb.26.1013. View

Curry Jr T, Osteen K . The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev. 2003; 24(4):428-65. DOI: 10.1210/er.2002-0005. View

Yang J, Wu M, Chen M, Chen S, Yang Y, Ho H . Increased matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 secretion but unaffected invasiveness of endometrial stromal cells in adenomyosis. Fertil Steril. 2008; 91(5 Suppl):2193-8. DOI: 10.1016/j.fertnstert.2008.05.090. View

Chung H, Lee J, Moon H, Hur S, Park M, Wen Y . Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium. Fertil Steril. 2002; 78(4):787-95. DOI: 10.1016/s0015-0282(02)03322-8. View

Inagaki N, Ung L, Otani T, Wilkinson D, Lopata A . Uterine cavity matrix metalloproteinases and cytokines in patients with leiomyoma, adenomyosis or endometrial polyp. Eur J Obstet Gynecol Reprod Biol. 2003; 111(2):197-203. DOI: 10.1016/s0301-2115(03)00244-6. View

Lessey B, Palomino W, Apparao K, Young S, Lininger R . Estrogen receptor-alpha (ER-alpha) and defects in uterine receptivity in women. Reprod Biol Endocrinol. 2006; 4 Suppl 1:S9. PMC: 1679803. DOI: 10.1186/1477-7827-4-S1-S9. View

Parrott E, Butterworth M, Green A, White I, Greaves P . Adenomyosis--a result of disordered stromal differentiation. Am J Pathol. 2001; 159(2):623-30. PMC: 1850567. DOI: 10.1016/S0002-9440(10)61733-6. View

Birkedal-Hansen H, Moore W, Bodden M, Windsor L, DeCarlo A, Engler J . Matrix metalloproteinases: a review. Crit Rev Oral Biol Med. 1993; 4(2):197-250. DOI: 10.1177/10454411930040020401. View

10.

Mori T, Yamasaki S, Masui F, Matsuda M, Sasabe H, Zhou Y . Suppression of the development of experimentally induced uterine adenomyosis by a novel matrix metalloproteinase inhibitor, ONO-4817, in mice. Exp Biol Med (Maywood). 2001; 226(5):429-33. DOI: 10.1177/153537020122600506. View

11.

Osteen K, Bruner-Tran K, Eisenberg E . Reduced progesterone action during endometrial maturation: a potential risk factor for the development of endometriosis. Fertil Steril. 2005; 83(3):529-37. DOI: 10.1016/j.fertnstert.2004.11.026. View

12.

Hirata M, Sato T, Tsumagari M, Shimada A, Nakano H, Hashizume K . Differential regulation of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases by cytokines and growth factors in bovine endometrial stromal cells and trophoblast cell line BT-1 in vitro. Biol Reprod. 2003; 68(4):1276-81. DOI: 10.1095/biolreprod.102.006452. View

13.

Matsuda M, Sasabe H, Adachi Y, Suzuki T, Mori T . Increased invasion activity of endometrial stromal cells and elevated expression of matrix metalloproteinase messenger RNA in the uterine tissues of mice with experimentally induced adenomyosis. Am J Obstet Gynecol. 2001; 185(6):1374-80. DOI: 10.1067/mob.2001.117967. View

14.

Levgur M, Abadi M, Tucker A . Adenomyosis: symptoms, histology, and pregnancy terminations. Obstet Gynecol. 2000; 95(5):688-91. DOI: 10.1016/s0029-7844(99)00659-6. View

15.

Devlieger R, DHooghe T, Timmerman D . Uterine adenomyosis in the infertility clinic. Hum Reprod Update. 2003; 9(2):139-47. DOI: 10.1093/humupd/dmg010. View

16.

Pavlok A, Lucas-Hahn A, Niemann H . Fertilization and developmental competence of bovine oocytes derived from different categories of antral follicles. Mol Reprod Dev. 1992; 31(1):63-7. DOI: 10.1002/mrd.1080310111. View

17.

Walter I, Boos A . Matrix metalloproteinases (MMP-2 and MMP-9) and tissue inhibitor-2 of matrix metalloproteinases (TIMP-2) in the placenta and interplacental uterine wall in normal cows and in cattle with retention of fetal membranes. Placenta. 2001; 22(5):473-83. DOI: 10.1053/plac.2001.0633. View

18.

Hashizume K, Takahashi T, Shimizu M, Todoroki J, Shimada A, Hirata M . Matrix-metalloproteinases-2 and -9 production in bovine endometrial cell culture. J Reprod Dev. 2004; 49(1):45-53. DOI: 10.1262/jrd.49.45. View